Congratulations Dr. Weber and the Island retina team for FDA approval of the Lucerne study - A new eye treatment called Vabysmo
Oculis
(Diamond 2 Study)
For Diabetic Macular Edema (DME)
Enrollment is Open (Shirley Office Only)
About this Study
This is a phase 3 study investigating an eye drop to treat DME!
Alkeus
New Treatment for Stargardt’s Disease
Enrollment is Open
About this Study
This is a phase 2 study investigating an oral pill of modified vitamin A
Opthea
(Coast Study)
New Treatment for Neovascular Age-Related Macular Degeneration
Enrollment is Closed
About this Study
This is a phase 3 study looking at adding a new molecule in addition to Lucentis or Eylea. It is hoped that patients will have better results and less frequent treatment.
Rezolute
New Treatment for diabetic macular edema(DME)
Enrollment is Open
About this Study
This is a phase 2 study investigating an oral medication to treat DME
Regenexbio
(Atmosphere Study)
New Treatment for Wet AMD
Enrollment is Open
About this Study
This is a gene therapy study on patients that have received previous intraocular injections as treatment. It is a one time surgical procedure.
Magic
New treatment for nonproliferative diabetic retinopathy
Enrollment is Open
About this Study
2 FDA approved drugs: Faricimab and Vabysmo will be given in early stages of the disease to investigate if this will lead to better outcomes
Aviceda
New Treatment for Geographic Atrophy associated with Dry Macular Degeneration
Enrollment is Open
About this Study
This is a phase 2 study looking at a new molecule to control Geographic atrophy. It is an injection into the back of the eye given monthly.
